Rationally Engineered

Not all Cyclodextrins are created equally

Captisol® is a patent protected, uniquely modified cyclodextrin, whose chemical structure was rationally designed to enable the creation of new products by significantly improving solubility, stability, bioavailability and dosing of active pharmaceutical ingredients (APIs).

Get Free SampleOrder Now

Social

December 17, 2018

Syros announces new preclinical data on SY-1365 at San Antonio Breast Cancer Symposium https://t.co/mxFtgcXgFO

Your Partner in Solubility
The Clear Advantage
Facilitate your drug discovery and development activities with Liquid Captisol®

Facilitate your drug discovery and development activities with Liquid Captisol®

learn more

Partners

Merck
Baxter
Pfizer
Bristol-Myers Squibb
Amgen
Melinta
Lundbeck
Lilly
Celgene
Spectrum Pharmaceuticals